Alpha 2.0
Login Register
» Articles » PMID: 36469841

Yes, We Can, But Should We? Ethical Considerations in Reporting Germline Findings From Paired Tumor-Normal Genomic Testing in Patients With Advanced Cancer

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2022 Dec 5
PMID 36469841
Authors
Cynthia L Hunter
Paul R Helft
Affiliations
Soon will be listed here.
Citing Articles

Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications.

Laguna J, Pastor B, Nalda I, Hijazo-Pechero S, Teixido C, Potrony M Br J Cancer. 2024; 130(9):1420-1431.

PMID: 38532104 PMC: 11059286. DOI: 10.1038/s41416-024-02607-9.

Personalized medicine with germline pathogenic variants: Importance of population- and region-wide evidence.

Usui Y, Momozawa Y Cancer Sci. 2023; 114(10):3816-3824.

PMID: 37530079 PMC: 10551596. DOI: 10.1111/cas.15922.